MedPath

Effectiveness of Digital Health Management on Patients With Head and Neck Vascular Stenosis

Not Applicable
Not yet recruiting
Conditions
Head and Neck Vascular Stenosis
Interventions
Behavioral: Digital health management
Registration Number
NCT05798013
Lead Sponsor
Yi Yang
Brief Summary

The purpose of this study is to evaluate the effectiveness of digital health management for intervention on Chinese population with head and neck vascular stenosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
102072
Inclusion Criteria
  1. Inclusion criteria of the clusters

    Hospitals with the qualification of "head and neck ultrasound center" in China.

  2. Inclusion criteria for individuals

    • (1)Age ≥ 35 years old, with no restriction on gender.
    • (2)Patients with clinically diagnosed head and neck stenosis or occlusion, including mild, moderate or severe stenosis or occlusion of the carotid artery and mild, moderate or severe stenosis or occlusion of the intracranial artery.
    • (3)Ability to use a smartphone and have a mobile application installed on the handset.
    • (4)Subjects or their legal representatives agreed to the study and signed the project informed consent form.
Exclusion Criteria
  1. Exclusion criteria for the clusters

    The included centers did not have the capacity to undertake the trial.

  2. Exclusion criteria for individuals

    • (1)Combination of severe systemic diseases such as respiratory failure, renal failure, gastrointestinal bleeding, coagulation dysfunction, malignancy, etc.
    • (2)Patients with a life expectancy of less than 2 years or who are unable to complete the study for other reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Digital health management intervention GroupDigital health managementPatients in the trial group receives intervention management from the digital health management platform, including reminding patients to take medication on time, monitoring and managing risk factors, reminding patients to have regular checkups and regular follow-ups, and pushing personalized science based on patients' risk factors, etc. Meanwhile, the platform's customer service staff regularly follows up with patients and reminds them of health management, and regularly invites experts to conduct formal medical science conferences for patients.
Primary Outcome Measures
NameTimeMethod
New-onset stroke events at 24 months24 months

New-onset stroke events include ischemic stroke, transient ischemic attack, and hemorrhagic stroke.

Secondary Outcome Measures
NameTimeMethod
Composite and separate indicators of new clinical vascular events at 12 and 24 months12 months, 24 months

Clinical vascular events included ischemic stroke, transient ischemic attack, hemorrhagic stroke, myocardial infarction, and vascular death.

New-onset stroke events at 12 months12 months

New-onset stroke events include ischemic stroke, transient ischemic attack, and hemorrhagic stroke.

All-cause deaths at 24 months24 months

Trial Locations

Locations (1)

First Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

© Copyright 2025. All Rights Reserved by MedPath